Call For More Information (410) Skype715-2111
Blog: Recent Posts
  1. Advancements in Prenatal Genetic Tests – Noninvasive

    New prenatal genetic tests hold promise, worries By Carolyn Y. Johnson SWANSEA — On a stormy Valentine’s Day in 2007, Courtney Kane felt herself detach from her body and float up to the ceiling. She watched as the figure below, 19 weeks pregnant, reclined on a bed in an exam...
  2. Society’s Distorted Views on Downs Syndrome

    Deciding Not to Screen for Down Syndrome By LISA BELKIN Amy Julia Becker is expecting her third child in January. She is 32 years old, and her age, plus the fact that her first child was born with Down syndrome, magnifies her odds of a chromosomal abnormality in this pregnancy, leading...

Sign up for our blog!


Technical Information

Ravgen’s core technology is based on its ability to increase the percentage of fetal DNA that is found in the mother’s blood.  Through its research with free floating fetal DNA, the company has developed and patented a variety of noninvasive prenatal tests that simply require a safe blood draw from the mother.  Currently, the focus for Ravgen’s core technology is on testing for single gene disorders, such as cystic fibrosis, sickle cell anemia, and the Jewish panel, as well as prenatal paternity testing.

Image1Pic

 

Image2Pic

 

ChromosomeAnalogyPic